"It Only Lasts 3 Hours": The Anatomy of a Common ADHD Stimulant Complaint

ADHD stimulant users often report that Vyvanse and other extended-release amphetamine formulations “only last three hours,” and the piece explains this mismatch between labeled duration of action and subjective relief. The core claim is that therapeutic motivation and executive control effects can persist across the day, while the salience peak that signals early “something important is happening” tends to fade after a few hours. That early phase can feel like the medication’s whole effect, especially after dose initiation or titration. The post frames patient complaints as a mix of neuropharmacology and cognitive-emotional narrative: hopes for sustained relief, frustration when the initial “honeymoon” fades, and differing outcome priorities such as executive function, affective stability, sleep quality, and quality of life. It also suggests that persistent issues may warrant workup and consideration of switching formulations or strategies, with symptom and outcome journaling over time.